Clinical Trials Directory

Trials / Unknown

UnknownNCT04309071

Saliva Insulin Responses to a Standardized Meal Tolerance Test in Humans

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
18 Years – 69 Years
Healthy volunteers
Accepted

Summary

Recent evidence suggests that hyperinsulinemia (i.e., elevated insulin levels) is the primary causative factor in obesity. Insulin promotes fat storage and prevents fat breakdown, suggesting that weight loss would be optimized if insulin levels are managed and kept low. Understanding how different foods impact insulin levels could therefore aid in personalized weight loss (or weight maintenance) advice. It has been shown that salivary insulin can track plasma insulin following different meals and can delineate between lean and obese people. Thus, it was suggested that salivary insulin could be a potential surrogate for plasma insulin. The purpose of this study is to measure fasting saliva insulin, and salivary insulin responses to a standardized meal tolerance test in individuals with different body mass index (BMI).

Conditions

Interventions

TypeNameDescription
OTHERDietary interventionSalivary insulin responses to a standardized mixed meal

Timeline

Start date
2019-01-04
Primary completion
2022-06-01
Completion
2022-09-01
First posted
2020-03-16
Last updated
2021-09-28

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04309071. Inclusion in this directory is not an endorsement.